SHANMU
Latest round
- Series A
Last raised
- May 2026
Total raised
- $15M
Investors
- 9
About SHANMU
, trading as SHANMU, operates as a digital healthcare services company that focuses on the research and development of home health monitoring products. It was recognized as the National High-tech Enterprise. The team members come from UCLA, Tsinghua University, Manchester University, and other universities. Hequan Lin, the CEO of the company, graduated from the Georgia Institute of Technology and used to found Mercury Bionics. The company has applied for 53 patents. The company's main product is a real-time urinalysis health management robot, SHANMU S1, combining multi-spectrum sensing chips and AI algorithms, which can read and analyze more than 10 types of urine metabolism indexes, covering kidney function, endocrine, acid-base balance, etc. The data can be viewed through the SHANMU APP, which explains abnormal indicators and medical advice. Its perception series products have completed controlled clinical trials in several hospitals. The company mainly generates revenue from the sale of miniature home AI health management products and related services.
Who invested in SHANMU
9 investors across 2 rounds
See all investors in SHANMU
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SHANMU
Who invested in SHANMU?
SHANMU has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SHANMU raised?
SHANMU has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SHANMU last raise money?
SHANMU's most recent round on record is a Series A, in May 2026.
What does SHANMU do?
, trading as SHANMU, operates as a digital healthcare services company that focuses on the research and development of home health monitoring products.
Where is SHANMU headquartered?
SHANMU is headquartered in Shenzhen, China.
Which VCs invest in companies like SHANMU?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at SHANMU's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like SHANMU? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.